UK Study Integrates PrecivityAD2 Blood Test for Alzheimer’s in Primary Care
Researchers in the United Kingdom are integrating the PrecivityAD2 blood test from C2N Diagnostics into the Alzheimer’s disease…
ALZpath, Alamar Biosciences Expand Agreement for Alzheimer’s Blood Diagnostics
ALZpath and Alamar Biosciences have expanded their strategic agreement to include clinical diagnostics for Alzheimer’s disease. The broadened…
Alzheimer’s Biomarkers Predict Cognitive Decline in Patients Over 80
Researchers at the Sant Pau Research Institute found that Alzheimer’s disease biomarkers can predict rapid cognitive decline in…